press release

Technimark Commits to Bold Climate Action and Achieves EcoVadis Gold Medal

Back

Technimark Commits to Bold Climate Action and Achieves EcoVadis Gold Medal

Asheboro, NC

|

Asheboro, NC – October 15, 2024 – Technimark, a global leader in manufacturing solutions for healthcare, consumer packaging, and specialty industrial markets, announced today a major commitment to combat climate change. The company will finalize and submit science-based greenhouse gas (GHG) emissions reduction targets for validation by the Science Based Targets initiative (SBTi), positioning Technimark at the forefront of corporate climate action.

As a testament to its comprehensive sustainability efforts, Technimark has also been awarded the prestigious Gold Medal by EcoVadis, the world’s largest provider of business sustainability ratings. This accolade places Technimark among the top 4% of companies evaluated globally for their performance in environment, labor and human rights, ethics, and responsible sourcing. 

The pursuit of SBTi validation builds upon Technimark’s 2030 goals across its key pillars of People, Planet, and Product. As highlighted in its 2023 Sustainability Brief, Technimark is committed to a 42% reduction in its direct greenhouse gas emissions (Scope 1 and 2) by 2030. This includes emissions from its own operations and purchased energy. Now, Technimark is raising the bar higher by developing a new target to address indirect emissions (Scope 3) throughout its entire value chain. 

“Our commitment to SBTi validation and the recognition from EcoVadis underscores our proactive approach to sustainability,” says Brad Wellington, President and Chief Executive Officer of Technimark. “We’re setting ambitious targets and taking concrete steps to transform our operations, aiming to inspire industry-wide change through our actions.”

“At Technimark, we believe that true leadership in sustainability requires constant evolution,” adds Katie Distler, Chief Sustainability Officer at Technimark. “By aligning our climate targets with the latest scientific standards, we’re not just reducing our environmental footprint – we’re paving the way for a more sustainable future in manufacturing. The EcoVadis Gold Medal serves as a testament to our comprehensive approach to responsible business practices.”

Technimark’s commitment to science-based targets and its EcoVadis Gold status represent significant milestones in the company’s sustainability journey. By implementing rigorous sustainability practices and setting ambitious goals, Technimark aims to create a ripple effect throughout its supply chain and the broader manufacturing sector. This approach not only addresses the company’s direct environmental impact but also encourages partners, suppliers, and competitors to elevate their own sustainability standards, potentially leading to a collective reduction in the industry’s carbon footprint.

As the company moves forward, it remains dedicated to innovating sustainable solutions, fostering a culture of environmental responsibility, and creating long-term value for its customers, employees, and the communities it serves.

Posted in News, SustainabilityTagged in , , ,

Technimark’s Mexicali Facility is Fourth to Earn MedAccred™ Certification

MEXICALI, MEXICO, (August 15, 2024) – Technimark, a global manufacturing leader for the medical market, announced today that their facility in Mexicali, Mexico is now MedAccred Certified in Plastics by the Performance Review Institute (PRI). Providing rigorous qualification for medical devices, the Performance Review Institute offers MedAccred certification through industry managed and approved standards to ensure critical manufacturing quality for medical devices. 

Bolstered by increased investment in additional cleanrooms and increasing the size of the facility, Mexicali marks the fourth plant that is MedAccred certified following our facilities in El Paso, Texas, Latrobe, Pennsylvania, and Longford, Ireland. Adding another MedAccred certified location to demonstrates Technimark’s commitment to standards developed by medical device OEMs, contract manufacturers, and suppliers. The MedAccred certification evaluates five distinct areas of focus including:

  • Consistent and standardized process 
  • Subject matter experts on-site
  • Greater supply chain visibility
  • Ensuring the easy transfer of knowledge to sub-tier suppliers
  • Applying industry-accepted and consistent technical requirements to production

In addition to the certification of the facility in Mexicali, Technimark is seeking further accreditation of two other locations by 2025. 

“Obtaining MedAccred and other industry certifications are essential to demonstrate our commitment to excellence,” stated Kris Peavy, Chief Commercial Officer, and President of Healthcare at Technimark. “We want our customers to know our commitment is to the highest manufacturing standards in the industry.”

Achieving these rigorous standards throughout a thorough and complex audit process demonstrates Technimark’s commitment to the continued improvement and enhancement of medical manufacturing. By adhering to the highest manufacturing standards throughout our global facilities, we provide quality and performance assurances for customers and consumers across the world. 

About Technimark

Technimark is a global manufacturing solutions provider for the healthcare, consumer packaging, and specialty industrial market. Technimark specializes in precision injection molding, value-added assembly, and full supply chain services. Technimark provides clients with customized, end-to-end solutions based on technology and innovation that improve quality, reduce risk, lower costs, and speed products to market. With facilities in the United States, Mexico, United Kingdom, Ireland, Germany, and China, Technimark delivers high-quality products worldwide. For more information, visit technimark.com.

Posted in NewsTagged in , , ,

Technimark Debuts Ambitious 2030 Goals in Newly Released Sustainability Brief

ASHEBORO, NC – JUNE 4, 2024 – Technimark, a global leader in plastic injection molding for healthcare, packaging, and specialty industrial markets, announced today the release of its 2023 Sustainability Brief, unveiling ambitious 2030 sustainability goals and detailing performance across three core pillars of People, Planet, and Product.

“Fostering a workplace where every employee can thrive, minimizing our environmental footprint, and delivering innovative products that responsibly provide value has always been fundamental to our business and growth,” said Brad Wellington, Technimark President and CEO.  “Over the past year, we challenged ourselves to accelerate the positive impact we have on the issues that matter most to our stakeholders. Our 2030 goals now serve as our North Star, guiding us forward with focus and commitment.”

The 2023 Sustainability Brief debuts Technimark’s 2030 vision and outlines a comprehensive sustainability strategy. The strategy is informed by an in-depth materiality assessment and aimed at reducing the leading global manufacturer’s climate impact, zeroing out waste to landfill, fostering a diverse and inclusive culture, and advancing sustainability and circularity across the plastics value chain. Additionally, the brief provides a disclosure of performance in alignment with the Sustainability Accounting Standards Board (SASB) transparently highlighting Technimark’s 2023 progress in preparation for expanded reporting against its new goals in the future. Highlights of the brief include:

  • Setting a 2030 target to reduce Scope 1 and 2 greenhouse gas emissions by 42% compared to a 2021 baseline, in line with limiting global warming to 1.5° C
  • Reducing Scope 1 and 2 market-based emissions by over 24% since 2021
  • Diverting more than 85% of waste from landfill or incineration at the majority of Technimark locations
  • Decreasing water consumption more than 12 percent from 2022 to 2023
  • 98 percent of purchased wood fiber from certified sustainable sources
  • A 2023 EcoVadis silver medal, highlighting the company’s sustainability performance within the top 9% of all rated companies and the top 5% within its industry

“Technimark embraces sustainability as a cornerstone of our business model. This brief highlights our strengths and successes but also where we can improve in our efforts to build a more sustainable future,” says Katie Distler, Technimark’s Corporate Vice President, ESG. “At Technimark, sustainability is on all of us. We measure and report on the impact of our initiatives so that everyone knows the difference we’re making — and where we need to work harder. Continuous improvement, innovation, and passion are in our DNA.”  

The 2023 Sustainability Brief is available at https://www.technimark.com/documents/technimark-sustainability/ and references relevant sector standards from SASB, the Global Reporting Initiative, and the United Nations Global Compact.

—

About Technimark

Technimark is a global manufacturing solutions provider for the healthcare, consumer packaging, and specialty industrial market. Technimark specializes in precision injection molding, value-added assembly, and full supply chain services. Technimark provides clients with customized, end-to-end solutions based on technology and innovation that improve quality, reduce risk, lower costs, and speed products to market. With facilities in the United States, Mexico, United Kingdom, Ireland, Germany, and China, Technimark delivers high-quality products worldwide. For more information, visit technimark.com.

Posted in News, SustainabilityTagged in , ,

Technimark Earns MedAccred Certification for El Paso Facility

Company currently pursuing new industry standard MedAccred certification for its other medical device facilities worldwide

ASHEBORO, N.C. (Jul, 6, 2021) – Technimark announced today that its production facility in El Paso, Texas, received its MedAccred certification from the Performance Review Institute. The facility, which is also ISO 13485:2016 certified and 21 CFR 820 compliant, specializes in medical contract manufacturing, including services such as custom injection molding, assembly and logistics operations for the medical device industry.

“Patient safety and quality are our highest priorities, and we are excited to partner with MedAccred to ensure our critical processes are best-in-class,” said Kris Peavy, president of Technimark’s Healthcare division. “The significant growth of our medical device business around the world, and specifically in our El Paso facility, made MedAccred certification a perfect fit. The accreditation helps us further demonstrate our expertise as a trustworthy and high-quality supplier in the medical device industry.  We’re currently pursuing accreditation at all of our medical facilities, and we expect them to be certified in the near future.”

The MedAccred certification program was developed by the Performance Review Institute, a non-for-profit organization that facilitates collaborative supply chain oversight programs, quality management systems approvals and professional development activities in industries that rely on high-quality, high-safety protocols. MedAccred is managed by the medical device OEMs, contract manufacturers and suppliers who collaborate to provide the sector with a trustworthy, evidence-based tool to ensure the suppliers’ processes and products meet the highest standards and improve product quality.

“Technimark is clearly committed to quality and improving patient safety by meeting the rigorous requirements set by technical experts in the medical device industry,” said Connie Conboy, director, MedAccred. “Technimark is a true leader in the medical device industry as demonstrated by their MedAccred Accreditation for Plastics Injection Molding at their El Paso, Texas facility.”

In describing the MedAccred certification process, the Performance Review Institute notes that preventing output deficiencies requires that critical processes and products be validated during manufacturing to prove that they are fit for purpose, satisfy regulatory requirements and reduce overall risk. The MedAccred certification does just this by:

  • Providing consistent, standardized critical process accreditation accepted by the Medical Device Industry resulting in fewer redundant onsite audits by multiple OEMs
  • Having Subject Matter Experts conduct in-depth critical process audits that are compliant and consistent with accepted industry/technical standards
  • Providing greater visibility of the supply chain to all levels and sub-tiers that provide critical processes, consistent with regulatory requirements (e.g., FDA, ISO 13485, MDD/MDR, etc.)
  • Improving the flow down of OEM requirements to sub-tier suppliers
  • Applying medical device industry-accepted and consistent technical requirements that yield process discipline, greater operational efficiency and continuous improvement resulting in higher quality and lower overall cost

Mr. Peavy explained that the audit is very thorough and drills into each individual process under review. “While MedAccred certification requires an ISO-certified quality management system, the process is not simply a QMS audit. Rather, it focuses on the key elements of the manufacturing process itself,” he said.

Audits are conducted by industry-approved and trained SME auditors on behalf of its subscribing OEM members using collaboratively created audit criteria. The accreditation is granted and accepted by the program’s subscribing OEM members. The audit criteria incorporate industry-accepted performance standards and manufacturer specifications that meet regulatory requirements.

“On behalf of Technimark and our clients, I want to thank the entire El Paso team for leading the way on this notable achievement,” Mr. Peavy said.


About Technimark

Technimark is a global manufacturing solutions provider for the healthcare, consumer packaging and specialty industrial market. Technimark specializes in precision injection molding, value-added assembly and full supply chain services. Technimark provides clients with customized, end-to-end solutions based on technology and innovation that improve quality, reduce risk, lower costs and speed products to market. With facilities in the United States, Mexico, United Kingdom, Ireland, Germany and China, Technimark delivers high-quality products worldwide. For more information, visit technimark.com.

Posted in NewsTagged in , , ,

Oak Hill Capital Acquires Majority Stake in Technimark Holdings LLC

NEW YORK, June 7, 2021 – Oak Hill Capital (“Oak Hill”), a New York-based middle-market private equity firm, announced that it had agreed to acquire a controlling stake in Technimark Holdings LLC (“Technimark” or “the Company”) through Oak Hill’s fifth institutional fund, forming a partnership with current investors, Pritzker Private Capital (“PPC”) and management. The terms of the transaction were not disclosed.

Headquartered in Asheboro, North Carolina, Technimark is a leading designer and manufacturer of custom, highly-engineered injection molded components, which it sells to a group of global healthcare, consumer and specialty industrial customers. “We have a great deal of respect for what Technimark has accomplished, including its strong track-record of delivering industry leading quality and service to its customers,” said Brian Cherry, Managing Partner at Oak Hill. “We are delighted to partner with Technimark’s world class management team.”

“Technimark is a fantastic business with industry leading engineering and innovation capabilities and a very impressive list of global customers,” said John Rachwalski, a Partner at Oak Hill. “Thanks to strong leadership and smart, well-executed investments, Technimark is distinctively positioned to capitalize on the trends in its core target markets. We look forward to supporting the Company’s exciting growth agenda over the course of our partnership.”

The management team of Technimark, led by Chief Executive Officer Brad Wellington, will continue to lead the Company and retain a meaningful ownership stake. “Oak Hill is a firm that shares our collaborative culture and our growth vision for the business. We look forward to a successful partnership as we continue investing in Technimark’s manufacturing and innovation capabilities to drive best-in-class results for our customers,” said Wellington.

William Blair & Company served as financial advisor to Oak Hill on the transaction and Goldman Sachs & Co and Wells Fargo Securities, LLC acted as financial advisor to Technimark. Paul, Weiss, Rifkind, Wharton & Garrison LLP is serving as legal advisor to Oak Hill and Kirkland & Ellis LLP is serving as legal counsel to Technimark and PPC.

The transaction is expected to close in the third quarter of 2021 and represents the ninth investment in the Oak Hill Capital Partners V portfolio.

About Technimark Holdings LLC

Technimark is a global manufacturing solutions provider for the healthcare, consumer packaging and specialty industrial markets. Technimark specializes in precision injection molding, value-added assembly and full supply chain services. Technimark provides clients with customized, end-to-end solutions based on technology and innovation that improve quality, reduce risk, lower costs and speed products to market. With facilities in the United Kingdom, United States, Mexico, China and Germany, Technimark delivers high-quality products worldwide. For more information, visit www.technimark.com.

About Oak Hill Capital

Oak Hill Capital is a private equity firm managing funds with over $16 billion of initial capital commitments and co-investments since inception. Over the past 35 years, Oak Hill Capital and its predecessors have invested in approximately 100 private equity transactions across broad segments of the U.S. and global economies. Oak Hill Capital applies an industry-focused, theme-based approach to investing in the following sectors: Industrials, Services, Media & Communications, and Consumer. Oak Hill works actively in partnership with management to implement strategic and operational initiatives to create franchise value. For more information, please visit: www.oakhill.com.

About Pritzker Private Capital

Pritzker Private Capital partners with middle-market companies based in North America with leading positions in the manufactured products, services and healthcare sectors. The firm’s differentiated, long-duration capital base allows for efficient decision-making, broad flexibility with transaction structure and investment horizon, and alignment with all stakeholders. Pritzker Private Capital builds businesses for the long term and is an ideal partner for entrepreneur- and family-owned companies. Pritzker Private Capital is a signatory to the United Nations Principles for Responsible Investment (PRI). For more information, visit www.PPCPartners.com.

Media Contacts:
Dawn Dover / Emma Cloyd
Kekst CNC
917-349-5621 / 646-629-1191
dawn.dover@kekstcnc.com / emma.cloyd@kekstcnc.com

SOURCE Oak Hill Capital Partners

Posted in Employee info, NewsTagged in , ,

Technimark Expands Role of Key Executive

Technimark is pleased to announce that Kris Peavy, Technimark’s Chief Commercial Officer, has also been named President of Technimark Healthcare. This will expand Kris’ current accountabilities to include P&L oversight for our global Healthcare business. In this role, Kris will be able to provide more support to Technimark’s rapidly growing Healthcare segment to ensure strategic growth and profitability. 

Kris has been with Technimark since 2010 and has been instrumental in helping build Technimark’s Healthcare business. The expansion of his responsibility will enable him to support the division for the future.   

Posted in Employee infoTagged in ,

Technimark Invests to Grow Healthcare Business

Access to Increased Resources and Technology Appeals to Customers

Asheboro, N.C. — With its recent acquisition of Ci Medical Technologies, Technimark, a global manufacturer of custom rigid plastic packaging and components, launched a separate medical division, Technimark Healthcare.

“The new division expands Technimark’s decade-old healthcare business by combining our global footprint, technical capabilities and financial resources with Ci Medical’s blue-chip customer base,” said Kris Peavy, senior vice president of sales and marketing for Technimark. “We were especially excited to add Ci Medical’s extensive experience in the healthcare market, including product development, scientific molding, contract manufacturing, assembly, packaging and logistics.”

Technimark serves customers worldwide from its 11 manufacturing facilities across North America, Europe and Asia. Mr. Peavy noted the company has prepared for rapid growth in its healthcare business over the past 18 months by doubling the size of its facilities in Germany and China as well as building new state-of-the-art facilities in Mexico and Asheboro, N.C. Operations at Technimark Healthcare facilities meet applicable ANSI and ISO standards and FDA regulations for the manufacture of medical products, including insulin pumps, surgical tools and other specialized devices.

“Since the acquisition six months ago, we’ve built a dedicated healthcare team that’s already providing added value to our customers by combining the individual strengths of Technimark and Ci Medical,” said Mr. Peavy.

The reception from both current and prospective customers has been universally positive, Mr. Peavy said, noting that client retention has been 100 percent. “Over its many years in business, Ci Medical built an enviable track record of success,” he said. “When we first began to explore the possibility of joining forces to build on that success, both organizations recognized immediately what a remarkable fit this would be.

“Combining what Technimark brought to the table – access to capital, global resources and technological know-how – with Ci Medical’s expertise and client roster, we knew Technimark Healthcare would be a new Tier One health products and packaging company in the industry,” Mr. Peavy said. “Our customers see those opportunities, and they’re ready to grow with us.”

——–

Ci Medical was founded in Pennsylvania in 1971 as Classic Industries, Inc. As the company grew, it specialized in injection-molded components for medical, pharmaceutical and healthcare applications worldwide. Technimark is a world-class, custom injection molder for the world’s most admired companies and respected brands in the healthcare, consumer packaging and industrial markets. Established more than 40 years ago, Technimark is one of the top 10 molders in North America with nearly 3,300 employees. For more information, visit Technimark.com.

Posted in NewsTagged in , , , ,

Technimark promotes John Rugari to VP Sales, Healthcare

Technimark would like to announce the promotion of John Rugari to Vice President of Sales, Technimark Healthcare, from his prior position as Director of Global Business Development, Healthcare. John comes to Technimark with over 20 years of executive level account and business development experience with Medplast and Nypro.

John joined our team in 2014 to help develop and deploy Technimark’s strategic plan as we entered into the Healthcare / Medical market. He has played a leading role in developing our Healthcare business plan and building a strong foundation for our future in Healthcare.

John’s promotion comes at an exciting time as we expand our capabilities into Healthcare manufacturing.

Posted in NewsTagged in , ,

Technimark acquires Ci Medical Technologies

A new approach to healthcare manufacturing. Thanks to a new combination of resources.

Technimark has always been known for using innovative thinking to come up with new and better ways to get the job done. What you might not know is that this approach extends well beyond the manufacturing floor.

Case in point? Technimark recently announced the purchase of Ci Medical Technologies, a top manufacturer of injection-molded components used in medical, pharmaceutical and consumer healthcare products.

With the addition of Ci Medical’s medical expertise and worldwide infrastructure to our existing resources, we’re creating a new division: Technimark Healthcare. It’s not just about getting bigger; it’s about sharpening our focus on the healthcare market, so we’re better able to serve customers around the world.

Operations at Ci Medical meet ANSI and ISO standards and FDA regulations for the products it manufactures, including insulin pumps, surgical tools and other specialized devices. All of which complements Technimark’s parallel development of a robust healthcare manufacturing infrastructure, including class 8 clean rooms and ISO 13485 certification.

By combining Technimark’s innovative technology-based offering, strong balance sheet and global scale with Ci’s medical market experience, infrastructure and deep capabilities, we’re uniquely positioned to meet a full range of needs today—and to provide many new technologies, solutions and manufacturing options in the future.

Download Press Release here: Technimark Acquires Ci Medical – Press Release – 12-08-15

Posted in NewsTagged in , , ,